GB202219335D0 - Therapy - Google Patents

Therapy

Info

Publication number
GB202219335D0
GB202219335D0 GBGB2219335.3A GB202219335A GB202219335D0 GB 202219335 D0 GB202219335 D0 GB 202219335D0 GB 202219335 A GB202219335 A GB 202219335A GB 202219335 D0 GB202219335 D0 GB 202219335D0
Authority
GB
United Kingdom
Prior art keywords
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2219335.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Linnane Pharma AB
Original Assignee
Linnane Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Linnane Pharma AB filed Critical Linnane Pharma AB
Priority to GBGB2219335.3A priority Critical patent/GB202219335D0/en
Publication of GB202219335D0 publication Critical patent/GB202219335D0/en
Priority to PCT/IB2023/059909 priority patent/WO2024075003A1/en
Ceased legal-status Critical Current

Links

GBGB2219335.3A 2022-10-03 2022-12-21 Therapy Ceased GB202219335D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2219335.3A GB202219335D0 (en) 2022-12-21 2022-12-21 Therapy
PCT/IB2023/059909 WO2024075003A1 (en) 2022-10-03 2023-10-03 A complex comprising a alpha-lactalbumin and a fatty acid or lipid for use in the treatment or prevention of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2219335.3A GB202219335D0 (en) 2022-12-21 2022-12-21 Therapy

Publications (1)

Publication Number Publication Date
GB202219335D0 true GB202219335D0 (en) 2023-02-01

Family

ID=85035786

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2219335.3A Ceased GB202219335D0 (en) 2022-10-03 2022-12-21 Therapy

Country Status (1)

Country Link
GB (1) GB202219335D0 (en)

Similar Documents

Publication Publication Date Title
EP4090369A4 (en) Pericyte-sparing therapy
GB202108303D0 (en) Therapy
GB202315877D0 (en) Therapy
GB202306826D0 (en) Therapy
GB202306833D0 (en) Therapy
GB202306835D0 (en) Therapy
GB202303026D0 (en) Therapy
GB202219335D0 (en) Therapy
GB202218595D0 (en) Therapy
GB202215997D0 (en) Therapy
GB202214514D0 (en) Therapy
GB202318311D0 (en) Combination therapy
GB202317996D0 (en) Combination therapy
GB202316168D0 (en) Combination therapy
GB202315149D0 (en) Combination therapy
GB202314243D0 (en) Combination therapy
GB202314157D0 (en) Combination therapy
GB202306663D0 (en) Combination therapy
GB202218974D0 (en) Combination therapy
GB202207792D0 (en) Combination therapy
GB202205317D0 (en) Combination therapy
GB202201346D0 (en) Combination therapy
GB202208779D0 (en) Combined therapy
GB202117706D0 (en) Therapy
GB202111035D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)